Parvoduk

RSS

Lapsed

This medicine's authorisation has lapsed

live attenuated Muscovy duck parvovirus
MedicineVeterinaryLapsed

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Parvoduk has lapsed because it has not been marketed in the European Union in the three years following the granting of the authorisation.

български (BG) (279.17 KB - PDF)

Vizualizare

español (ES) (388.86 KB - PDF)

Vizualizare

čeština (CS) (432.85 KB - PDF)

Vizualizare

dansk (DA) (386.36 KB - PDF)

Vizualizare

Deutsch (DE) (392.74 KB - PDF)

Vizualizare

eesti (ET) (372.5 KB - PDF)

Vizualizare

ελληνικά (EL) (456.39 KB - PDF)

Vizualizare

français (FR) (390.28 KB - PDF)

Vizualizare

hrvatski (HR) (547.54 KB - PDF)

Vizualizare

italiano (IT) (391.31 KB - PDF)

Vizualizare

latviešu (LV) (456.12 KB - PDF)

Vizualizare

lietuvių (LT) (421.48 KB - PDF)

Vizualizare

magyar (HU) (449.76 KB - PDF)

Vizualizare

Malti (MT) (440.69 KB - PDF)

Vizualizare

Nederlands (NL) (388.36 KB - PDF)

Vizualizare

polski (PL) (432.82 KB - PDF)

Vizualizare

português (PT) (389.06 KB - PDF)

Vizualizare

română (RO) (418.94 KB - PDF)

Vizualizare

slovenčina (SK) (436.71 KB - PDF)

Vizualizare

slovenščina (SL) (428.53 KB - PDF)

Vizualizare

suomi (FI) (387.48 KB - PDF)

Vizualizare

svenska (SV) (386.11 KB - PDF)

Vizualizare

Product information

български (BG) (1.19 MB - PDF)

Vizualizare

español (ES) (804.6 KB - PDF)

Vizualizare

čeština (CS) (1.03 MB - PDF)

Vizualizare

dansk (DA) (817.13 KB - PDF)

Vizualizare

Deutsch (DE) (901.86 KB - PDF)

Vizualizare

eesti (ET) (803.72 KB - PDF)

Vizualizare

ελληνικά (EL) (1.2 MB - PDF)

Vizualizare

français (FR) (816.73 KB - PDF)

Vizualizare

hrvatski (HR) (1.23 MB - PDF)

Vizualizare

italiano (IT) (816.1 KB - PDF)

Vizualizare

latviešu (LV) (1.05 MB - PDF)

Vizualizare

lietuvių (LT) (953.35 KB - PDF)

Vizualizare

magyar (HU) (997.58 KB - PDF)

Vizualizare

Malti (MT) (1.06 MB - PDF)

Vizualizare

Nederlands (NL) (808.14 KB - PDF)

Vizualizare

polski (PL) (1.17 MB - PDF)

Vizualizare

português (PT) (803.42 KB - PDF)

Vizualizare

română (RO) (936.44 KB - PDF)

Vizualizare

slovenčina (SK) (1.06 MB - PDF)

Vizualizare

slovenščina (SL) (1.06 MB - PDF)

Vizualizare

suomi (FI) (791.59 KB - PDF)

Vizualizare

svenska (SV) (796.96 KB - PDF)

Vizualizare

Íslenska (IS) (803.26 KB - PDF)

Vizualizare

norsk (NO) (815.13 KB - PDF)

Vizualizare
Latest procedure affecting product information:R/0006
09/01/2019

български (BG) (189.97 KB - PDF)

Vizualizare

español (ES) (281.53 KB - PDF)

Vizualizare

čeština (CS) (304.72 KB - PDF)

Vizualizare

dansk (DA) (298.36 KB - PDF)

Vizualizare

Deutsch (DE) (302.28 KB - PDF)

Vizualizare

eesti (ET) (285.5 KB - PDF)

Vizualizare

ελληνικά (EL) (325.92 KB - PDF)

Vizualizare

français (FR) (335.93 KB - PDF)

Vizualizare

hrvatski (HR) (307.68 KB - PDF)

Vizualizare

italiano (IT) (299.37 KB - PDF)

Vizualizare

latviešu (LV) (340.5 KB - PDF)

Vizualizare

lietuvių (LT) (297.31 KB - PDF)

Vizualizare

magyar (HU) (303.78 KB - PDF)

Vizualizare

Malti (MT) (306.38 KB - PDF)

Vizualizare

Nederlands (NL) (313.36 KB - PDF)

Vizualizare

polski (PL) (299.63 KB - PDF)

Vizualizare

português (PT) (297.7 KB - PDF)

Vizualizare

română (RO) (312.51 KB - PDF)

Vizualizare

slovenčina (SK) (304.5 KB - PDF)

Vizualizare

slovenščina (SL) (297.92 KB - PDF)

Vizualizare

suomi (FI) (295.81 KB - PDF)

Vizualizare

svenska (SV) (293.03 KB - PDF)

Vizualizare

Íslenska (IS) (292.58 KB - PDF)

Vizualizare

norsk (NO) (298.06 KB - PDF)

Vizualizare

Product details

Name of medicine
Parvoduk
Active substance
live attenuated Muscovy duck parvovirus
International non-proprietary name (INN) or common name
live attenuated Muscovy duck parvovirus
Species
Ducks
Anatomical therapeutic chemical veterinary (ATCvet) code
QI01BD03

Pharmacotherapeutic group

  • duck parvovirus
  • Live viral vaccines
  • Immunologicals for aves

Therapeutic indication

Active immunisation of ducks to prevent mortality1 and to reduce weight loss and lesions of duck parvovirosis and Derzsy's disease.


1In absence of maternally derived antibodies.

Authorisation details

EMA product number
EMEA/V/C/002740
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
11/04/2014
Lapse of marketing authorisation
01/04/2019
Revision
2

Assessment history

This page was last updated on

Share this page